| NDC Code | 49281-323-50 |
|---|
| Package Description | 10 SYRINGE, GLASS in 1 PACKAGE (49281-323-50) / .5 mL in 1 SYRINGE, GLASS (49281-323-88) |
|---|
| Product NDC | 49281-323 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Fluzone Quadrivalent Southern Hemisphere |
|---|
| Non-Proprietary Name | Influenza A Virus A/sydney/5/2021 San-013 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/darwin/9/2021 San-010 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated), And Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated) |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20230213 |
|---|
| End Marketing Date | 20231231 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA103914 |
|---|
| Manufacturer | Sanofi Pasteur Inc. |
|---|
| Substance Name | INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SYDNEY/5/2021 SAN-013 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) |
|---|
| Strength | 15; 15; 15; 15 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
|---|